Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Entheon Biomedical Corp (OP: ENTBF ) 0.0947 UNCHANGED Streaming Delayed Price Updated: 9:57 AM EDT, Aug 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.0947 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0947 Today's Range 0.0947 - 0.0947 52wk Range 0.0043 - 0.2000 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them August 30, 2022 The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... Via Benzinga PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program August 03, 2022 Via Investor Brand Network Performance YTD +1179.73% +1179.73% 1 Month -2.17% -2.17% 3 Month -14.68% -14.68% 6 Month -10.32% -10.32% 1 Year +406.42% +406.42% More News Read More PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Expected to Accelerate Clinical Development Path of CYB004 July 11, 2022 Via Investor Brand Network Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill June 15, 2022 Via Benzinga Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin June 07, 2022 Via Benzinga Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research June 01, 2022 Via Benzinga Entheon Biomedical Announces Non-Brokered Private Placement Financing April 05, 2022 Via Benzinga Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th February 09, 2022 Via Benzinga Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins February 07, 2022 Via Benzinga Psychedelics Biotech Startup Launches Phase 1 Study On Ayahuasca's Active Ingredient February 03, 2022 Via Benzinga Entheon Biomedical Reports Launching Multiple Studies to Advance Psychedelic-Based Mental Health Treatments December 13, 2021 Via Benzinga Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) Featured in Virtual Coverage of Benzinga’s Small Cap Conference December 07, 2021 Via Investor Brand Network Compass Pathways 2.0: A New Rally In Psychedelic Stocks? November 04, 2021 Via Talk Markets Topics Initial Public Offering Exposures Securities Market Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials October 27, 2021 Via Newsfile Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 Via Benzinga Entheon Biomedical Acquires Lobo Genetics, Inc. in Bid to Strengthen Screening and Treatment Evaluation Tech for Psychedelics October 06, 2021 Via Benzinga There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Via Benzinga Clinical Director of Imperial College's Center for Psychedelic Research Joins Entheon Advisory Board August 25, 2021 Via Newsfile Entheon Biomedical Corp. Announces DTC Eligibility August 24, 2021 Via Newsfile CORRECTION FROM SOURCE: BTV Examines the Rapidly Expanding Psychedelics Market August 17, 2021 Via Newsfile BTV Examines the Rapidly Expanding Psychedelics Market August 17, 2021 Via Newsfile Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine August 12, 2021 Via Newsfile Exposures Product Safety Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected August 02, 2021 Via Benzinga Entheon Biomedical Corp. Strengthens Its Psychedelic-Assisted Protocols Through Acquisition Of Lobo Genetics July 30, 2021 Via Benzinga Entheon Biomedical Corp. Acquires Lobo Genetics Inc. July 30, 2021 Via Newsfile Topics Cannabis Exposures Cannabis Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
